A carregar...
Adenosine A(2A) receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation
GVHD is a major barrier to broader use of allogenic HSCT for nonmalignancy clinical applications such as the treatment of primary immunodeficiencies and hemoglobinopathies. We show in a murine model of C57BL/6J (H2-k(b)) → B6D2F1/J (H2-k(b/d)) acute GVHD that when initiated 2 days before transplant,...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Society for Leukocyte Biology
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2812560/ https://ncbi.nlm.nih.gov/pubmed/19889728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.0609388 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|